000			02111 a2200625 4500
005			20250516151443.0
264		0	_c20130718
008			201307s 0 0 eng d
022			_a2168-619X
024	7		_a10.1001/jamaoto.2013.1810 _2doi
040			_aNLM _beng _cNLM
100	1		_aRogers, Derek J
245	0	0	_aUse of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. _h[electronic resource]
260			_bJAMA otolaryngology-- head & neck surgery _cMay 2013
300			_a496-501 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAge Factors
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aBevacizumab
650	0	4	_aBiopsy, Needle
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCohort Studies
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInjections, Intralesional
650	0	4	_aLaryngeal Neoplasms _xdrug therapy
650	0	4	_aLaryngoscopy _xmethods
650	0	4	_aLaser Therapy _xmethods
650	0	4	_aMale
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aPapillomavirus Infections _xdrug therapy
650	0	4	_aPilot Projects
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aReoperation _xstatistics & numerical data
650	0	4	_aRespiratory Tract Infections _xdrug therapy
650	0	4	_aRisk Assessment
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aOjha, Shilpa
700	1		_aMaurer, Rie
700	1		_aHartnick, Christopher J
773	0		_tJAMA otolaryngology-- head & neck surgery _gvol. 139 _gno. 5 _gp. 496-501
856	4	0	_uhttps://doi.org/10.1001/jamaoto.2013.1810 _zAvailable from publisher's website
999			_c22757983 _d22757983